title: Psychosis risk syndrome: is it worth the risk?
abstract: The American Psychiatric Association is considering listing the 'Psychosis Risk Syndrome' as a diagnosis in its own right in the DSM-5. This decision recognises the paradigm shift in clinical psychiatry to a model of early intervention. However, this decision has aroused much discussion. The controversy which has arisen around this proposal reflects the difficulties in implementing the early intervention paradigm. Here we review the different opinions which have been expressed regarding this issue and consider whether this is the appropriate time to include 'Psychosis Risk Syndrome' as an independently listed psychiatric diagnosis.
authors.affiliation: University of Cambridge, School of Clinical Medicine, Cambridge, UK.
authors.forename: Chang-Ho
authors.initials: CH
authors.lastname: Yoon
authors.forename: Mark
authors.initials: M
authors.lastname: Agius
authors.forename: Rashid
authors.initials: R
authors.lastname: Zaman
mesh_terms: D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D018450:Disease Progression; D061345:Early Medical Intervention; D006801:Humans; D062706:Prodromal Symptoms; D011618:Psychotic Disorders / Q000145:classification / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D012306:Risk; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents